Cambridge tech ecosystem soars to $191B in value, says Dealroom: Here are the citys 10 largest tech funding rounds of 2024
Summary
With this capability, the company can facilitate a wide range of tasks, such as conducting a first review of contracts and detecting contractual irregularities, identifying areas of non-compliance, and applying advanced Al-driven ECA and TAR for Discovery matters. The company is currently developing two small molecule drugs, MTX652 (peripheral) and MTX325 (targeting the CNS) which, through inhibition of the mitochondrial DUB enzyme USP30, will promote clearance of dysfunctional mitochondria – consequently improving overall cellular health. Their patented technology has produced a design for a switched reluctance motor (SRM) that reduces torque ripple by 50% across the drive cycle, resulting in a smoother and quieter performance. Sano has developed a software platform that connects patients living with rare and chronic conditions, such as Long Covid, multiple sclerosis, Parkinson’s, and Alzheimer’s, directly with biotech and pharma companies leading personalised medicine research Qureight is a clinical data analytics company that aims to accelerate clinical trial development at key decision points through data curation and AI-powered decision-making. To address this, PlaqueTec has developed a proprietary technology and data analysis platform to endotype patients and uncover potential biomarkers of coronary vascular function and plaque progression.